Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998
- 1 March 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 23 (3), 261-265
- https://doi.org/10.1097/00042560-200003010-00009
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort studyThe Lancet, 1999
- Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patientsAIDS, 1998
- Metabolic abnormalities and use of HIV-1 protease inhibitorsThe Lancet, 1998
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998
- Visceral abdominal-fat accumulation associated with use of indinavirThe Lancet, 1998
- Changes in AIDS incidence for men who have sex with men, United States 1990–1995AIDS, 1997
- A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 InfectionNew England Journal of Medicine, 1995
- Plasma lipids in HIV‐infected patients: a prospective study in 95 patientsEuropean Journal of Clinical Investigation, 1994
- Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1992
- Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndromeAmerican Journal Of Medicine, 1991